Back to User profile » Dr Marco Lanza
Papers published by Dr Marco Lanza:
Efficacy of CR4056, a first-in-class imidazoline-2 analgesic drug, in comparison with naproxen in two rat models of osteoarthritis
Comi E, Lanza M, Ferrari F, Mauri V, Caselli G, Rovati LC
Journal of Pain Research 2017, 10:1033-1043
Published Date: 4 May 2017
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats
Meregalli C, Ceresa C, Canta A, Carozzi VA, Chiorazzi A, Sala B, Oggioni N, Lanza M, Letari O, Ferrari F, Avezza F, Marmiroli P, Caselli GF, Cavaletti G
Journal of Pain Research 2012, 5:151-167
Published Date: 20 June 2012
Analgesic efficacy of CR4056, a novel imidazoline-2 receptor ligand, in rat models of inflammatory and neuropathic pain
Ferrari F, Fiorentino S, Mennuni L, Garofalo P, Letari O, Mandelli S, Giordani A, Lanza M, Caselli G
Journal of Pain Research 2011, 4:111-125
Published Date: 18 April 2011